1. Home
  2. RAND vs NEPH Comparison

RAND vs NEPH Comparison

Compare RAND & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAND
  • NEPH
  • Stock Information
  • Founded
  • RAND 1969
  • NEPH 1997
  • Country
  • RAND United States
  • NEPH United States
  • Employees
  • RAND N/A
  • NEPH N/A
  • Industry
  • RAND Finance: Consumer Services
  • NEPH Medical/Dental Instruments
  • Sector
  • RAND Finance
  • NEPH Health Care
  • Exchange
  • RAND Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • RAND 54.4M
  • NEPH 45.3M
  • IPO Year
  • RAND N/A
  • NEPH 2004
  • Fundamental
  • Price
  • RAND $15.21
  • NEPH $4.29
  • Analyst Decision
  • RAND
  • NEPH Strong Buy
  • Analyst Count
  • RAND 0
  • NEPH 2
  • Target Price
  • RAND N/A
  • NEPH $5.50
  • AVG Volume (30 Days)
  • RAND 4.8K
  • NEPH 45.8K
  • Earning Date
  • RAND 11-05-2025
  • NEPH 11-06-2025
  • Dividend Yield
  • RAND 11.40%
  • NEPH N/A
  • EPS Growth
  • RAND N/A
  • NEPH N/A
  • EPS
  • RAND N/A
  • NEPH 0.12
  • Revenue
  • RAND $7,966,118.00
  • NEPH $16,684,000.00
  • Revenue This Year
  • RAND N/A
  • NEPH $24.38
  • Revenue Next Year
  • RAND N/A
  • NEPH $10.16
  • P/E Ratio
  • RAND N/A
  • NEPH $36.92
  • Revenue Growth
  • RAND 1.16
  • NEPH 21.16
  • 52 Week Low
  • RAND $13.82
  • NEPH $1.36
  • 52 Week High
  • RAND $31.89
  • NEPH $5.00
  • Technical
  • Relative Strength Index (RSI)
  • RAND 46.04
  • NEPH 55.82
  • Support Level
  • RAND $14.50
  • NEPH $3.62
  • Resistance Level
  • RAND $15.25
  • NEPH $4.94
  • Average True Range (ATR)
  • RAND 0.66
  • NEPH 0.39
  • MACD
  • RAND 0.03
  • NEPH 0.01
  • Stochastic Oscillator
  • RAND 31.70
  • NEPH 50.76

About RAND Rand Capital Corporation

Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: